Abstrakt

Przypisy

• 1. Al-Wadei H.A., Al-Wadei M.H., Schuller H.M.: Cooperative regulationof non-small cell lung carcinoma by nicotinic and β-adrenergicreceptors: a novel target for intervention. PLoS One, 2012; 7: e29915
  Google Scholar
• 2. Benowitz N.L.: Drug therapy. Pharmacologic aspects of cigarettesmoking and nicotine addition. N. Engl. J. Med., 1988; 319: 1318-1330
  Google Scholar
• 3. Brognard J., Clark A.S., Ni Y., Dennis P.A.: Akt/protein kinase Bis constitutively active in non-small cell lung cancer cells and promotescellular survival and resistance to chemotherapy and radiation.Cancer Res., 2001; 61: 3986-3997
  Google Scholar
• 4. Browman G.P., Wong G., Hodson I., Sathya J., Russell R., McAlpineL., Skingley P., Levine M.N.: Influence of cigarette smoking onthe efficacy of radiation therapy in head and neck cancer. N. Engl.J. Med., 1993; 328: 159-163
  Google Scholar
• 5. Brown K.C., Perry H.E., Lau J.K., Jones D.V., Pulliam J.F., ThornhillB.A., Crabtree C.M., Luo H., Chen Y.C., Dasgupta P.: Nicotine inducesthe up-regulation of the α7-nicotinic receptor (α7-nAChR) in humansquamous cell lung cancer cells via the Sp1/GATA protein pathway.J. Biol. Chem., 2013; 288: 33049-33059
  Google Scholar
• 6. Carlisle D.L., Liu X., Hopkins T.M., Swick M.C., Dhir R., SiegfriedJ.M.: Nicotine activates cell-signaling pathways through muscle-typeand neuronal nicotinic acetylcholine receptors in non-small cell lungcancer cells. Pulm. Pharmacol. Ther., 2007; 20: 629-641
  Google Scholar
• 7. Chen G.Q., Lin B., Dawson M.I., Zhang X.K.: Nicotine modulatesthe effects of retinoids on growth inhibition and RAR beta expressionin lung cancer cells. Int. J. Cancer, 2002; 99: 171-178
  Google Scholar
• 8. Chernyavsky A.I., Shchepotin I.B., Galitovkiy V., Grando S.A.:Mechanisms of tumor-promoting activities of nicotine in lung cancer:synergistic effects of cell membrane and mitochondrial nicotinicacetylcholine receptors. BMC Cancer, 2015; 15: 152
  Google Scholar
• 9. Dasgupta P., Kinkade R., Joshi B., Decook C., Haura E., ChellappanS.: Nicotine inhibits apoptosis induced by chemotherapeuticdrugs by up-regulating XIAP and survivin. Proc. Natl. Acad. Sci.USA, 2006; 103: 6332-6337
  Google Scholar
• 10. Dasgupta P., Rastogi S., Pillai S., Ordonez-Ercan D., Morris M.,Haura E., Chellappan S.: Nicotine induces cell proliferation byβ-arrestin-mediated activation of Src and Rb-Raf-1 pathways. J. Clin.Invest., 2006; 116: 2208-2217
  Google Scholar
• 11. Dasgupta P., Rizwani W., Pillai S., Kinkade R., Kovacs M., RastogiS., Banerjee S., Carless M., Kim E., Coppola D., Haura E., ChellappanS.: Nicotine induces cell proliferation, invasion and epithelial-mesenchymaltransition in a variety of human cancer cell lines. Int. J.Cancer, 2009; 124: 36-45
  Google Scholar
• 12. de Graan A.J., Loos W.J., Friberg L.E., Baker S.D., van der Bol J.M.,van Doorn L., Wiemer E.A., van der Holt B., Verweij J., MathijssenR.H.: Influence of smoking on the pharmacokinetics and toxicityprofiles of taxane therapy. Clin. Cancer Res., 2012; 18: 4425-4432
  Google Scholar
• 13. Filosto S., Becker C.R., Goldkorn T.: Cigarette smoke inducesaberrant EGF receptor activation that mediates lung cancer developmentand resistance to tyrosine kinase inhibitors. Mol. CancerTher., 2012; 11: 795-804
  Google Scholar
• 14. Guo J., Kim D., Gao J., Kurtyka C., Chen H., Yu C., Wu D., Mittal A.,Beg A.A., Chellappan S.P., Haura E.B., Cheng J.Q.: IKBKE is induced bySTAT3 and tobacco carcinogen and determines chemosensitivity innon-small cell lung cancer. Oncogene, 2013; 32: 151-159
  Google Scholar
• 15. Guo L., Li L., Wang W., Pan Z., Zhou Q., Wu Z.: Mitochondrial reactiveoxygen species mediates nicotine-induced hypoxia-induciblefactor-1α expression in human non-small cell lung cancer cells. Biochim.Biophys. Acta, 2012; 1822: 852-861
  Google Scholar
• 16. Hamilton M., Wolf J.L., Rusk J., Beard S.E., Clark G.M., Witt K.,Cagnoni P.J.: Effects of smoking on the pharmacokinetics of erlotinib.Clin. Cancer Res., 2006; 12: 2166-2171
  Google Scholar
• 17. Heeschen C., Jang J.J., Weis M., Pathak A., Kaji S., Hu R.S., TsaoP.S., Johnson F.L., Cooke J.P.: Nicotine stimulates angiogenesis andpromotes tumor growth and atherosclerosis. Nat. Med., 2001; 7:833-839
  Google Scholar
• 18. Heusch W.L., Maneckjee R.: Signalling pathways involved innicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis,1998; 19: 551-556
  Google Scholar
• 19. Hukkanen J., Jacob P.3rd, Benowitz N.L.: Metabolism and dispositionkinetics of nicotine. Pharmacol. Rev., 2005; 57: 79-115
  Google Scholar
• 20. Jin Z., Gao F., Flagg T., Deng X.: Nicotine induces multi-site phosphorylationof Bad in association with suppression of apoptosis. J.Biol. Chem., 2004; 279: 23837-23844
  Google Scholar
• 21. Khan E.M., Lanir R., Danielson A.R., Goldkorn T.: Epidermalgrowth factor receptor exposed to cigarette smoke is aberrantlyactivated and undergoes perinuclear trafficking. FASEB J., 2008; 22:910-917
  Google Scholar
• 22. Lau J.K., Brown K.C., Thornhill B.A., Crabtree C.M., Dom A.M.,Witte T.R., Hardman W.E., McNees C.A., Stover C.A., Carpenter A.B.,Luo H., Chen Y.C., Shiflett B.S., Dasgupta P.: Inhibition of cholinergicsignaling causes apoptosis in human bronchioalveolar carcinoma.Cancer Res., 2013; 73: 1328-1339
  Google Scholar
• 23. Losert D., Pratscher B., Soutschek J., Geick A., Vornlocher H.P.,Müller M., Wacheck V.: Bcl-2 downregulation sensitizes nonsmallcell lung cancer cells to cisplatin, but not to docetaxel. AnticancerDrugs, 2007; 18: 755-761
  Google Scholar
• 24. Mai H., May W.S, Gao F., Jin Z., Deng X.: A functional role fornicotine in Bcl2 phosphorylation and suppression of apoptosis. J.Biol. Chem., 2003; 278: 1886-1891
  Google Scholar
• 25. Maneckjee R., Minna J.D.: Opioids induce while nicotine suppressesapoptosis in human lung cancer cells. Cell Growth Differ.,1994; 5: 1033-1040
  Google Scholar
• 26. Nakada T., Kiyotani K., Iwano S., Uno T., Yokohira M., YamakawaK., Fujieda M., Saito T., Yamazaki H., Imaida K., Kamataki T.: Lungtumorigenesis promoted by anti-apoptotic effects of cotinine, a nicotinemetabolite through activation of PI3K/Akt pathway. J. Toxicol.Sci., 2012; 37: 555-563
  Google Scholar
• 27. Nishioka T., Guo J., Yamamoto D., Chen L., Huppi P., Chen C.Y.:Nicotine, through upregulating pro-survival signaling, cooperateswith NNK to promote transformation. J. Cell Biochem., 2010; 109:152-161
  Google Scholar
• 28. Nishioka T., Luo L.Y., Shen L., He H., Mariyannis A., Dai W., ChenC.: Nicotine increases the resistance of lung cancer cells to cisplatinthrough enhancing Bcl-2 stability. Br. J. Cancer, 2014; 110: 1785-1792
  Google Scholar
• 29. Nishioka T., Yamamoto D., Zhu T., Guo J., Kim S.H., Chen C.Y.:Nicotine overrides DNA damage-induced G1/S restriction in lungcells. PLoS One, 2011; 6: e18619
  Google Scholar
• 30. O›Malley M., Healy P., Daignault S., Ramnath N.: Cigarette smokingand gemcitabine-induced neutropenia in advanced solid tumors.Oncology, 2013; 85: 216-222
  Google Scholar
• 31. Park P.G., Merryman J., Orloff M., Schuller H.M.: Beta-adrenergicmitogenic signal transduction in peripheral lung adenocarcinoma:implications for individuals with preexisting chronic lung disease.Cancer Res., 1995; 55: 3504-3508
  Google Scholar
• 32. Peng X.H., Karna P., Cao Z., Jiang B.H., Zhou M., Yang L.: Crosstalkbetween epidermal growth factor receptor and hypoxia-induciblefactor-1α signal pathways increases resistance to apoptosis byup-regulating survivin gene expression. J. Biol. Chem., 2006; 281:25903-25914
  Google Scholar
• 33. Shin V.Y.,. Wu W.K, Chu K.M., Wong H.P., Lam E.K., Tai E.K., KooM.W., Cho C.H.: Nicotine induces cyclooxygenase-2 and vascularendothelial growth factor receptor-2 in association with tumorassociatedinvasion and angiogenesis in gastric cancer. Mol. CancerRes., 2005; 3: 607-615
  Google Scholar
• 34. Shin V.Y., Wu W.K., Ye Y.N.,. So W.H, Koo M.W., Liu E.S., Luo J.C.,Cho C.H.: Nicotine promotes gastric tumor growth and neovascularizationby activating extracellular signal-regulated kinase andcyclooxygenase-2. Carcinogenesis, 2004; 25: 2487-2495
  Google Scholar
• 35. Sopori M.: Effects of cigarette smoke on the immune system.Nat. Rev. Immunol., 2002; 2: 372-377
  Google Scholar
• 36. Tsurutani J., Castillo S.S., Brognard J., Granville C.A., ZhangC., Gills J.J., Sayyah J., Dennis P.A.: Tobacco components stimulateAkt-dependent proliferation and NFκB-dependent survival in lungcancer cells. Carcinogenesis, 2005; 26: 1182-1195
  Google Scholar
• 37. Videtic G.M., Stitt L.W., Dar A.R., Kocha W.I., Tomiak A.T., TruongP.T., Vincent M.D., Yu E.W.: Continued cigarette smoking bypatients receiving concurrent chemoradiotherapy for limited-stagesmall-cell lung cancer is associated with decreased survival. J. Clin.Oncol., 2003; 21: 1544-1549
  Google Scholar
• 38. Volm M., Samsel B., Mattern J.: Relationship between chemoresistanceof lung tumours and cigarette smoking. Br. J. Cancer,1990; 62: 255-256
  Google Scholar
• 39. Wang S., Takayama K., Tanaka K., Takeshita M., Nakagaki N.,Ijichi K., Li H., Nakanishi Y.: Nicotine induces resistance to epidermalgrowth factor receptor tyrosine kinase inhibitor by α1 nicotinicacetylcholine receptor-mediated activation in PC9 cells. J. Thorac.Oncol., 2013; 8: 719-725
  Google Scholar
• 40. Warren G.W., Romano M.A., Kudrimoti M.R., Randall M.E., Mc-Garry R.C., Singh A.K., Rangnekar V.M.: Nicotinic modulation oftherapeutic response in vitro and in vivo. Int. J. Cancer, 2012; 131:2519-2527
  Google Scholar
• 41. West K.A., Brognard J., Clark A.S., Linnoila I.R., Yang X., SwainS.M., Harris C., Belinsky S., Dennis P.A.: Rapid Akt activation by nicotineand a tobacco carcinogen modulates the phenotype of normalhuman airway epithelial cells. J. Clin. Invest., 2003; 111: 81-90
  Google Scholar
• 42. Wu S.Q., Lv Y.E., Lin B.H., Luo L.M., Lv S.L., Bi A.H., Jia Y.S.: Silencingof periostin inhibits nicotine-mediated tumor cell growthand epithelial-mesenchymal transition in lung cancer cells. Mol.Med. Rep., 2013; 7: 875-880
  Google Scholar
• 43. Xu L., Deng X.: Protein kinase Ciota promotes nicotine-inducedmigration and invasion of cancer cells via phosphorylation of microandm-calpains. J. Biol. Chem., 2006; 281: 4457-4466
  Google Scholar
• 44. Yu G.P., Ostroff J.S., Zhang Z.F., Tang J., Schantz S.P.: Smokinghistory and cancer patient survival: a hospital cancer registry study.Cancer Detect. Prev., 1997; 21: 497-509
  Google Scholar
• 45. Zevin S., Benowitz N.L. Drug interactions with tobacco smoking.An update. Clin. Pharmacokinet., 1999; 36: 425-438
  Google Scholar
• 46. Zhang J., Kamdar O., Le W., Rosen G.D., Upadhyay D.: Nicotine inducesresistance to chemotherapy by modulating mitochondrial signalingin lung cancer. Am. J. Respir. Cell Mol. Biol., 2009; 40: 135-146
  Google Scholar
• 47. Zhang Q., Tang X., Zhang Z.F., Velikina R., Shi S., Le A.D.: Nicotineinduces hypoxia-inducible factor-1α expression in human lungcancer cells via nicotinic acetylcholine receptor-mediated signalingpathways. Clin. Cancer Res., 2007; 13: 4686-4694
  Google Scholar
• 48. Zhu B.Q., Heeschen C., Sievers R.E., Karliner J.S., Parmley W.W.,Glantz S.A., Cooke J.P.: Second hand smoke stimulates tumor angiogenesisand growth. Cancer Cell, 2003; 4: 191-196
  Google Scholar

Pełna treść artykułu